Literature DB >> 25348580

Pegylated interferon therapy of chronic hepatitis D: in need of revision.

Mario Rizzetto1, Antonina Smedile.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25348580     DOI： 10.1002/hep.27585

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  9 in total

1.  Cost-Effectiveness of Peg-Interferon, Interferon and Oral Nucleoside Analogues in the Treatment of Chronic Hepatitis B and D Infections in China.

Authors:  Ashish Goyal; John M Murray
Journal:  Clin Drug Investig       Date:  2016-08       Impact factor: 2.859

2.  Hepatitis D infection: from initial discovery to current investigational therapies.

Authors:  Ben L Da; Theo Heller; Christopher Koh
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-06-23

3.  Efficacy and Safety of Bulevirtide plus Tenofovir Disoproxil Fumarate in Real-World Patients with Chronic Hepatitis B and D Co-Infection.

Authors:  Toni Herta; Magdalena Hahn; Melanie Maier; Janett Fischer; Johannes Niemeyer; Mario Hönemann; Albrecht Böhlig; Florian Gerhardt; Aaron Schindler; Jonas Schumacher; Thomas Berg; Johannes Wiegand; Florian van Bömmel
Journal:  Pathogens       Date:  2022-04-27

Review 4.  Therapy of Delta Hepatitis.

Authors:  Cihan Yurdaydin; Ramazan Idilman
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-07       Impact factor: 6.915

5.  Current and Future Management of Chronic Hepatitis D.

Authors:  Patrizia Farci; Grazia Anna Niro
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-06

Review 6.  New directions in hepatitis B therapy research.

Authors:  Marta Lewandowska; Anna Piekarska
Journal:  Clin Exp Hepatol       Date:  2017-07-05

7.  Recapitulation of HDV infection in a fully permissive hepatoma cell line allows efficient drug evaluation.

Authors:  Florian A Lempp; Franziska Schlund; Lisa Rieble; Lea Nussbaum; Corinna Link; Zhenfeng Zhang; Yi Ni; Stephan Urban
Journal:  Nat Commun       Date:  2019-05-22       Impact factor: 14.919

Review 8.  From hepatitis A to E: A critical review of viral hepatitis.

Authors:  Daniel Castaneda; Adalberto Jose Gonzalez; Mohammad Alomari; Kanwarpreet Tandon; Xaralambos Bobby Zervos
Journal:  World J Gastroenterol       Date:  2021-04-28       Impact factor: 5.742

Review 9.  Hepatitis delta virus: From infection to new therapeutic strategies.

Authors:  Grazia A Niro; Arianna Ferro; Francesca Cicerchia; Isabella Brascugli; Marilena Durazzo
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.